Chad Robins

Co-Founder & CEO
Adaptive Biotechnologies

 Mr. Robins is Adaptive’s Chief Executive Officer and Co-founder. He has held executive-level positions in real estate, investment banking, private equity and medical technology. In 2012, Mr. Robins was a “40 Under 40” Seattle Leaders honoree. In 2015, he and his brother, Harlan Robins, were honored as one of Goldman Sachs 100 Most Intriguing Entrepreneurs of the Year. Mr. Robins was a finalist for the Ernst & Young 2016 Entrepreneur of The Year® Award in the Pacific Northwest and won the award in 2017 along with his brother. While in college and looking for a way to combine his adventuresome spirit with a vast learning opportunity, he spent 100 days in the wilderness with the National Outdoor Leadership School (NOLs) where he gained his open and interactive leadership style along with his strong teamwork mentality. A Cornell University honors graduate with a major in entrepreneurship and business, Mr. Robins obtained his MBA from The Wharton School at the University of Pennsylvania with a major in finance and concentrations in marketing and operations. In addition to the Adaptive Biotechnologies board, Mr. Robins holds board positions for the American Heart Association (Puget Sound) and Pavia Systems. He is also the co-founder and Director of Aortica Corporation, a company that is simplifying endovascular repair (EVAR) for abdominal aortic aneurysms (AAA).